Immunocore Holdings plc (IMCR)
NASDAQ: IMCR · Real-Time Price · USD
31.63
+0.16 (0.51%)
Apr 14, 2026, 12:29 PM EDT - Market open
Immunocore Holdings Market Cap
Immunocore Holdings has a market cap or net worth of $1.6 billion as of April 14, 2026. Its market cap has increased by 6.27% in one year.
Market Cap
1.60B
Enterprise Value
1.17B
1-Year Change
6.27%
Ranking
Category
Stock Price
$31.63
Market Cap Chart
Since February 5, 2021, Immunocore Holdings's market cap has decreased from $1.80B to $1.60B, a decrease of -10.72%. That is a compound annual growth rate of -2.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 13, 2026 | 1.60B | -9.04% |
| Dec 31, 2025 | 1.75B | 18.83% |
| Dec 31, 2024 | 1.48B | -56.30% |
| Dec 29, 2023 | 3.38B | 23.54% |
| Dec 30, 2022 | 2.73B | 82.12% |
| Dec 31, 2021 | 1.50B | -16.41% |
| Feb 5, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Harmony Biosciences Holdings | 1.67B |
| Nurix Therapeutics | 1.66B |
| Rapport Therapeutics | 1.63B |
| Oculis Holding AG | 1.62B |
| Intellia Therapeutics | 1.59B |
| Nuvation Bio | 1.58B |
| Damora Therapeutics | 1.56B |
| Viridian Therapeutics | 1.53B |